Search Results 461-470 of 16881 for 4-week HIIT protocol

  1. A Study of the Efficacy of Lorcaserin for Weight Loss in Overweight Peri- and Postmenopausal Women - Mayo Clinic

    Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

  2. A Study to Improve Cardiovascular Health Among African Americans within Faith Communities - Mayo Clinic

    Sponsor Protocol Number: 18-006846. About this ... Guidelines differ from study to study ... Basic Internet navigation skills (at least weekly access).

  3. REDUCE LAP-HF TRIAL II - Mayo Clinic

    Sponsor Protocol Number: 1601. About this study ... 4 weeks prior to enrollment which is expected to be maintained for 6 months. ... LA diameter > 4 cm; or ...

  4. A Study of Inorganic Nitrite to Amplify the Benefits and Tolerability of Exercise Training in Heart Failure that has Preserved Ejection Fraction - Mayo Clinic

    ... 4) phases. Phase 0 trials are small trials that ... Austin, Minnesota: 16-001467. NCT ID: NCT02713126. Sponsor Protocol Number: 16-001467 ... week trial. The ...

  5. A Study to Investigate Mechanisms, Predictors, and Prevention of Persistent Post-Traumatic Headache - Mayo Clinic

    Sponsor Protocol Number: 19-003200. About this ... 5 or more moderate or severe headache days during the 4-week run-in phase. ... 4 days per month.

  6. Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Dialysis (ASCEND-D) - Mayo Clinic

    Sponsor Protocol Number: 200807. About this study ... (Week -8) through to randomization (Day 1). ... MI or acute coronary syndrome: ≤4 weeks prior to screening ...

  7. Cancer Treatment! Clinical Trials - Mayo Clinic Research

    The purpose of this study is to evaluate the rate of complete MRD response by flow cytometry after 4 weekly doses of daratumumab-hyaluronidase (Day 29) among ...

  8. Sarcoma Clinical Trials

    This trial is part of the CAMPFIRE master protocol which is a platform to accelerate the development of new treatments for pediatric and young adult ...

  9. Pilot Trial FETO for CDH - Mayo Clinic

    ... procedure, generally done when the baby has reached about 34 weeks gestation. The intent of the FETO procedure is to improve development of the lungs in ...

  10. Zephyrus II: Effectiveness and Safety Study of Pamrevlumab in Participants With Idiopathic Pulmonary Fibrosis (IPF) - Mayo Clinic

    to acute IPF exacerbation within 4 weeks prior to or during screening. 10. Recent use of any investigational drugs or unapproved therapies, or participation ...